While this case-controlled study needs to be replicated, it offers intriguing insights into novel ways to detect Alzheimer’s disease at its earliest stages. The work was funded by NIA, the University of Kentucky, Lexington, and Nanosomix, Inc.

http://www.nia.nih.gov/alzheimers/announcemen...rs-disease